245 related articles for article (PubMed ID: 19199652)
1. Biomedical application of orexin/hypocretin receptor ligands in neuroscience.
Boss C; Brisbare-Roch C; Jenck F
J Med Chem; 2009 Feb; 52(4):891-903. PubMed ID: 19199652
[No Abstract] [Full Text] [Related]
2. [Regulatory mechanism of sleep/wakefulness states by orexin].
Sakurai T
Tanpakushitsu Kakusan Koso; 2007 Nov; 52(14):1840-8. PubMed ID: 18018635
[No Abstract] [Full Text] [Related]
3. Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n,n-disubstituted-1,4-diazepane scaffold that promotes sleep in rats.
Whitman DB; Cox CD; Breslin MJ; Brashear KM; Schreier JD; Bogusky MJ; Bednar RA; Lemaire W; Bruno JG; Hartman GD; Reiss DR; Harrell CM; Kraus RL; Li Y; Garson SL; Doran SM; Prueksaritanont T; Li C; Winrow CJ; Koblan KS; Renger JJ; Coleman PJ
ChemMedChem; 2009 Jul; 4(7):1069-74. PubMed ID: 19418500
[TBL] [Abstract][Full Text] [Related]
4. Reply to 'Promotion of sleep by targeting the orexin system in rats, dogs and humans'.
Tafti M
Nat Med; 2007 May; 13(5):525-6; author reply 526. PubMed ID: 17479088
[No Abstract] [Full Text] [Related]
5. Role of the ventromedial hypothalamic orexin-1 receptors in regulation of gastric Acid secretion in conscious rats.
Eliassi A; Nazari M; Naghdi N
J Neuroendocrinol; 2009 Mar; 21(3):177-82. PubMed ID: 19207823
[TBL] [Abstract][Full Text] [Related]
6. The hypocretin/orexin receptor: therapeutic prospective in sleep disorders.
Nishino S
Expert Opin Investig Drugs; 2007 Nov; 16(11):1785-97. PubMed ID: 17970638
[TBL] [Abstract][Full Text] [Related]
7. Orexins and orexin receptors: from molecules to integrative physiology.
Matsuki T; Sakurai T
Results Probl Cell Differ; 2008; 46():27-55. PubMed ID: 18204827
[TBL] [Abstract][Full Text] [Related]
8. Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat.
Holland PR; Akerman S; Goadsby PJ
Eur J Neurosci; 2006 Nov; 24(10):2825-33. PubMed ID: 17156207
[TBL] [Abstract][Full Text] [Related]
9. Proline bis-amides as potent dual orexin receptor antagonists.
Bergman JM; Roecker AJ; Mercer SP; Bednar RA; Reiss DR; Ransom RW; Meacham Harrell C; Pettibone DJ; Lemaire W; Murphy KL; Li C; Prueksaritanont T; Winrow CJ; Renger JJ; Koblan KS; Hartman GD; Coleman PJ
Bioorg Med Chem Lett; 2008 Feb; 18(4):1425-30. PubMed ID: 18207395
[TBL] [Abstract][Full Text] [Related]
10. Food-elicited increases in cortical acetylcholine release require orexin transmission.
Frederick-Duus D; Guyton MF; Fadel J
Neuroscience; 2007 Nov; 149(3):499-507. PubMed ID: 17928158
[TBL] [Abstract][Full Text] [Related]
11. Effects of anesthetics on the function of orexin-1 receptors expressed in Xenopus oocytes.
Minami K; Uezono Y; Sakurai T; Horishita T; Shiraishi M; Ueta Y
Pharmacology; 2007; 79(4):236-42. PubMed ID: 17435392
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists.
Cole AG; Stroke IL; Qin LY; Hussain Z; Simhadri S; Brescia MR; Waksmunski FS; Strohl B; Tellew JE; Williams JP; Saunders J; Appell KC; Henderson I; Webb ML
Bioorg Med Chem Lett; 2008 Oct; 18(20):5420-3. PubMed ID: 18815029
[TBL] [Abstract][Full Text] [Related]
13. Regulation of food intake in the goldfish by interaction between ghrelin and orexin.
Miura T; Maruyama K; Shimakura S; Kaiya H; Uchiyama M; Kangawa K; Shioda S; Matsuda K
Peptides; 2007 Jun; 28(6):1207-13. PubMed ID: 17481778
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stress-induced ACTH responses in conscious rats.
Chang H; Saito T; Ohiwa N; Tateoka M; Deocaris CC; Fujikawa T; Soya H
Neurosci Res; 2007 Mar; 57(3):462-6. PubMed ID: 17188385
[TBL] [Abstract][Full Text] [Related]
15. Orexin receptor antagonists: a new concept in CNS disorders?
Gatfield J; Brisbare-Roch C; Jenck F; Boss C
ChemMedChem; 2010 Aug; 5(8):1197-214. PubMed ID: 20544785
[No Abstract] [Full Text] [Related]
16. Structural properties of orexins for activation of their receptors.
Lang M; Bufe B; De Pol S; Reiser O; Meyerhof W; Beck-Sickinger AG
J Pept Sci; 2006 Apr; 12(4):258-66. PubMed ID: 16138386
[TBL] [Abstract][Full Text] [Related]
17. [Orexins and pain processing].
Yamamoto T; Shono K
Masui; 2007 Jan; 56(1):40-7. PubMed ID: 17243644
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists.
Coleman PJ; Schreier JD; McGaughey GB; Bogusky MJ; Cox CD; Hartman GD; Ball RG; Harrell CM; Reiss DR; Prueksaritanont T; Winrow CJ; Renger JJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2311-5. PubMed ID: 20207138
[TBL] [Abstract][Full Text] [Related]
19. Orexin receptors as therapeutic drug targets.
Gotter AL; Roecker AJ; Hargreaves R; Coleman PJ; Winrow CJ; Renger JJ
Prog Brain Res; 2012; 198():163-88. PubMed ID: 22813974
[TBL] [Abstract][Full Text] [Related]
20. Orexin receptors: pharmacology and therapeutic opportunities.
Scammell TE; Winrow CJ
Annu Rev Pharmacol Toxicol; 2011; 51():243-66. PubMed ID: 21034217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
